FY25 Results Announcement
| Stock | Beamtree Holdings Ltd (BMT.ASX) |
|---|---|
| Release Time | 28 Aug 2025, 9:04 a.m. |
| Price Sensitive | Yes |
Beamtree Holdings Ltd Reports FY25 Results and Q4 Record
- Record Q4 with $3.2m increase in annual recurring revenue (ARR) to $29.2m
- Overall recurring revenue growth of 7% for FY25
- 78% increase in operating profit for FY25 to $0.7m
Beamtree Holdings Limited (ASX:BMT), a leading provider of AI-enabled decision support and data insights solutions for the healthcare sector, has released its financial results summary for the year ending 30 June 2025 (FY25) and a trading update. Key highlights include a record quarter with a $3.2m increase in annual recurring revenue (ARR) to a current ARR of $29.2m, an increase of 12% in one quarter and Q4 operating profit growth of 48% year on year. Overall, the company reported recurring revenue growth of 7% for FY25, driven by clinical coding growth in Australia and New Zealand (ANZ) and internationally, as well as customer renewals continuing at over 95%. The company also maintained disciplined cost management, with operating cost growth of only 2% in FY25, while still investing in international expansion and key software product development. This resulted in a 78% increase in operating profit for FY25 to $0.7m, as the company continues to focus on improving its financial performance. The strong Q4 momentum has continued into Q1 FY26, with the award of a ~$1m contract with the Ministry of Health of Singapore to provide an audit of the clinical coding and documentation in public and private hospitals. The company also reported significant customer and contract developments in FY25, including the launch of its new Integrated Coding Platform in Saudi Arabia, ongoing implementations of its new autonomous coding solution across Australia, Canada, and the UK, and the renewal of its partnership with the Healthcare Pricing Office in the Republic of Ireland.
The company has provided confidence around a medium-term target of $60m in annual recurring revenue (ARR).
The Q4 FY25 record ARR growth, the Q1 FY26 ongoing momentum, and relentless cost management give the Board and Management confidence of ongoing improved financial performance in FY26.